Review Article
Paving Plant-Food-Derived Bioactives as Effective Therapeutic Agents in Autism Spectrum Disorder
Table 3
Summary of in vivo studies.
| Phytocompounds | In vivo model | Results | References |
| Bisphenol A | Different ASD animal models | Modulates the function of the reproductive system, metabolism, and brain functions | [164] | Green tea | ASD mice model | Neuroprotective and antioxidant properties, and improvement of behavior | [166] | Piperine | ASD murine model | Antioxidant, neuroprotective, anxiolytic, and cognition-enhancing effects | [167–169] | Resveratrol | VPA-induced ASD rats | Activates sirtuins and decreases IL-6, TNF-α, NF-κB, and T cells | [80, 173] | Resveratrol | Propanoic acid-induced ASD rats | Reduces neuroinflammation, mitochondrial dysfunction, and oxidative/nitrosative stress | [81] | Curcumin | ASD rats | Increases GSH levels and reduces inflammation, mitochondrial dysfunction, and oxidative/nitrosative stress | [73, 176] | B. monnieri | ASD murine model | Improvement of behavior and antioxidant, anxiolytic, and analgesic properties | [181] | Ginsenoside-rich extract | ASD mice model | Improvement of behavior and locomotor activity | [83] | Co-ultra-PEA-LUT | ASD murine model | Reduces proimflammatory markers (nitrotyrosine and NF-κB), improves neuroplasticity and neurogenesis, and modulates apoptosis | [186] | PEA | BTBR T+tf/J mice | Reduces mitochondrial dysfunction and inflammatory effects Improvement of behavior, PPAR-α activation Microbiota-gut-brain axis regulation | [187] |
|
|